Related Experiment Video
Updated: Sep 30, 2025

Lung CT Segmentation to Identify Consolidations and Ground Glass Areas for Quantitative Assesment of SARS-CoV Pneumonia
Published on: December 19, 2020
Atypical presentation of an atypical pneumonia: a case report
Alvin Oliver Payus1, Clarita Clarence2, Tiong Nee3
1Medicine Based Department, Faculty of Medicine and Health Science, Universiti Malaysia Sabah (UMS), Jalan UMS, 88400, Kota Kinabalu, Sabah, Malaysia. dralvinpayus@ums.edu.my.
Background:
Neurologic impediments occur in only 0.1% of Mycoplasma pneumoniae infections. Although direct intracerebral infection can occur in these patients, autoimmune-mediated reactions secondary to molecular mimicry are the most common pathophysiology of such neurological complications. These complications include immune-mediated encephalitis, peripheral neuritis such as Guillain-Barré syndrome, and many others. Miller Fisher syndrome is a one of the variants of Guillain-Barré syndrome that has been rarely linked to Mycoplasma pneumoniae infection. It is a condition classically characterized by the triad of ophthalmoplegia, areflexia, and ataxia. Most patients with Miller Fisher syndrome will have positive anti-ganglioside GQ1b antibodies found in their serum, making this autoantibody a very useful serological confirmation parameter. We report a case of a Miller Fisher syndrome in a woman with Mycoplasma pneumoniae infection. To the best of the authors' knowledge, such cases have been only rarely described in literature.
Case Presentation:
A 35-year-old Chinese woman presented with sudden onset of double vision and ataxia 5 days after fever and mild flu symptoms. Her Mycoplasma pneumoniae antigen was positive with 1 over 2560 titer of total mycoplasma antibody and presence of immunoglobulin M antibody, suggesting acute infection, and her nerve conduction study revealed mild sensory axonal polyneuropathy with segmental demyelination. the Miller Fischer syndrome variant of Guillain-Barré syndrome secondary to Mycoplasma pneumonia was suspected and later confirmed by presence of serum anti-GQ1b autoantibody. She was treated with intravenous immunoglobulin 0.4 g/kg once daily for 5 days.
Conclusions:
The objective of this report is to share a case of an uncommon neurological complication of Mycoplasma pneumoniae infection, to increase the level of suspicion among clinicians that Miller Fischer syndrome can occur as an atypical presentation of an atypical pneumonia.
Insights
Mycoplasma pneumoniae infection can rarely cause Miller Fisher syndrome, a neurological disorder. This case highlights the importance of considering this rare complication in patients with Mycoplasma pneumoniae.
Area of Science:
- Neurology
- Infectious Diseases
- Immunology
Background:
- Mycoplasma pneumoniae infections are rarely associated with neurologic complications (0.1%).
- Neurological manifestations are typically autoimmune-mediated, often due to molecular mimicry.
- Miller Fisher syndrome, a variant of Guillain-Barré syndrome, is an uncommon neurological complication linked to Mycoplasma pneumoniae.
Observation:
- A 35-year-old woman presented with sudden-onset diplopia and ataxia following flu-like symptoms.
- Mycoplasma pneumoniae infection was confirmed by positive antigen and high antibody titers (IgM positive).
- Nerve conduction studies showed mild sensory axonal polyneuropathy with segmental demyelination.
Findings:
- The patient was diagnosed with Miller Fisher syndrome, a Guillain-Barré syndrome variant.
- Diagnosis was confirmed by the presence of serum anti-ganglioside GQ1b antibodies.
- Treatment involved a 5-day course of intravenous immunoglobulin.
Implications:
- This case underscores the importance of suspecting Miller Fisher syndrome in patients with Mycoplasma pneumoniae.
- It highlights an atypical neurological presentation of Mycoplasma pneumoniae infection.
- Increased clinical awareness can lead to earlier diagnosis and appropriate management of this rare condition.
More Related Videos
06:04Antigen-Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Mycoplasma pneumoniae
Published on: February 24, 2023
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...